hydromorphone has been researched along with tapentadol in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (83.33) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brockmöller, J; Friesacher, HR; Meyer, MJ; Neumann, VE; Tzvetkov, MV; Zdrazil, B | 1 |
| Glaser, PE; Rush, CR; Stoops, WW | 1 |
| Falke, D; Gálvez, R; Hans, G; Schäfer, M; Steigerwald, I | 1 |
| Bernardy, K; Häuser, W; Maier, C | 1 |
| Duse, G; Ferrari, R; Visentin, M; Zanolin, ME | 1 |
| Bell, RF; Derry, S; Moore, RA; Wee, B; Wiffen, PJ | 1 |
| Aruga, E; Takagi, Y | 1 |
| Ammar, D; Baron, L; Chvetzoff, G; Collin, E; Delorme, C; Delorme, T; Faure, S; Filbet, M; Hubault, P; Jovenin, N; Krakowski, I; Magnet, M; Michenot, N; Minello, C; Poulain, P; Rostaing, S | 1 |
| Brás, M; Fragoso, M; Vieira, C | 1 |
| Matsuda, Y; Niki, K; Okamoto, Y; Omae, T; Takagi, T; Takemura, M; Ueda, M | 1 |
| Atayee, RS; Edmonds, KP; Wen, RY | 1 |
6 review(s) available for hydromorphone and tapentadol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Long-term opioid therapy in chronic noncancer pain. A systematic review and meta-analysis of efficacy, tolerability and safety in open-label extension trials with study duration of at least 26 weeks].
Topics: Analgesics, Opioid; Buprenorphine; Chronic Pain; Hydromorphone; Long-Term Care; Morphine; Oxycodone; Oxymorphone; Pain Measurement; Phenols; Randomized Controlled Trials as Topic; Tapentadol; Tramadol; Treatment Outcome | 2015 |
Opioids for cancer pain - an overview of Cochrane reviews.
Topics: Acetaminophen; Administration, Cutaneous; Administration, Oral; Analgesics, Opioid; Buprenorphine; Cancer Pain; Codeine; Fentanyl; Humans; Hydromorphone; Methadone; Oxycodone; Phenols; Review Literature as Topic; Tapentadol; Tramadol | 2017 |
[New Opioid Options in Japan - Methadone, Tapentadol and Hydromorphone].
Topics: Analgesics, Opioid; Humans; Hydromorphone; Methadone; Pain Management; Phenols; Receptors, Opioid; Tapentadol | 2018 |
[Opioid switch and change of route of administration in cancer patients treated by morphine].
Topics: Administration, Oral; Analgesics, Opioid; Breakthrough Pain; Cancer Pain; Drug Substitution; Fentanyl; France; Humans; Hydromorphone; Injections, Intravenous; Injections, Subcutaneous; Methadone; Morphine; Oxycodone; Phenols; Tapentadol | 2018 |
[Opioids for Cancer Pain and its Use under Particular Conditions: A Narrative Review].
Topics: Administration, Oral; Analgesics, Opioid; Buprenorphine; Cancer Pain; Codeine; Deglutition Disorders; Fentanyl; Humans; Hydromorphone; Liver Failure; Morphine; Oxycodone; Renal Dialysis; Renal Insufficiency; Tapentadol; Tramadol | 2019 |
2 trial(s) available for hydromorphone and tapentadol
| Article | Year |
|---|---|
Miotic and subject-rated effects of therapeutic doses of tapentadol, tramadol, and hydromorphone in occasional opioid users.
Topics: Administration, Oral; Adult; Analgesics, Opioid; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hydromorphone; Male; Miosis; Phenols; Pupil; Receptors, Opioid, mu; Tapentadol; Time Factors; Tramadol; Young Adult | 2013 |
Tapentadol prolonged release versus strong opioids for severe, chronic low back pain: results of an open-label, phase 3b study.
Topics: Adult; Aged; Analgesics, Opioid; Buprenorphine; Chronic Pain; Constipation; Delayed-Action Preparations; Female; Fentanyl; Humans; Hydromorphone; Low Back Pain; Male; Middle Aged; Morphine; Neuralgia; Oxycodone; Pain Measurement; Phenols; Severity of Illness Index; Tapentadol | 2013 |
4 other study(ies) available for hydromorphone and tapentadol
| Article | Year |
|---|---|
Opioids as Substrates and Inhibitors of the Genetically Highly Variable Organic Cation Transporter OCT1.
Topics: Analgesics, Opioid; HEK293 Cells; Humans; Inhibitory Concentration 50; Models, Molecular; Organic Cation Transporter 1; Permeability; Protein Conformation | 2019 |
Effectiveness of opioid analgesics in chronic noncancer pain.
Topics: Adult; Aged; Analgesics, Opioid; Buprenorphine; Chronic Pain; Female; Fentanyl; Humans; Hydromorphone; Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; Opioid-Related Disorders; Oxycodone; Pain Clinics; Pain Measurement; Personality; Phenols; Prospective Studies; Quality of Life; Surveys and Questionnaires; Tapentadol; Treatment Outcome | 2015 |
Tapentadol in Cancer Patients with Neuropathic Pain: A Comparison of Methadone, Oxycodone, Fentanyl, and Hydromorphone.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Cancer Pain; Dose-Response Relationship, Drug; Female; Fentanyl; Humans; Hydromorphone; Japan; Male; Methadone; Middle Aged; Neoplasms; Neuralgia; Oxycodone; Pain Measurement; Retrospective Studies; Tapentadol | 2021 |
A Comparison of Institutional Opioid Equianalgesia Tools: A National Study.
Topics: Administration, Oral; Analgesics, Opioid; Fentanyl; Humans; Hydrocodone; Hydromorphone; Levorphanol; Morphine; Oxycodone; Tapentadol; Tramadol | 2022 |